JLE

Hépato-Gastro & Oncologie Digestive

MENU

Hépatite aiguë au paracétamol Volume 25, supplément 4, Décembre 2018

  • [1] Thomson J.S., Prescott L.F. Liver damage and impaired glucose tolerance after paracetamol overdosage. Br Med J. 1966;2:506-507. 5512
  • [2] Hider-Mlynarz K., Cavalié P., Maison P. Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. Br J Clin Pharmacol. 2018;84:1324-1334. 6
  • [3] Nourjah P., Ahmad S.R., Karwoski C., Willy M. Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 2006;15:398-405. 6
  • [4] Lee W.M. Recent developments in acute liver failure. Best Pract Res Clin Gastroenterol. 2012;26:3-16. 1
  • [5] Gulmez SE, Larrey D, Pageaux G-P, et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): The multinational case-population SALT study. Drug Saf 2013 ; 36 (2) : 135-44.
  • [6] Gulmez S.E., Larrey D., Pageaux G.-P. Liver transplant associated with paracetamol overdose: Results from the seven-country SALT study. Br J Clin Pharmacol. 2015;80:599-606. 3
  • [7] Larrey D., Meunier L., Pageaux G.-P. Drug exposure and risk of Acute Liver Failure leading to registration for liver Transplantation (ALFT): Results of the SALT III study in adults in France. J Hepatol. 2018;68:S587-S588.
  • [8] Kaplowitz N., DeLeve L.D. Drug-induced liver disease. Amsterdam: Elsevier; 2013.
  • [9] Win S., Than T.A., Han D., Petrovic L.M., Kaplowitz N. c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J Biol Chem. 2011;286:35071-35078. 40
  • [10] Jaeschke H., McGill M.R., Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev. 2012;44:88-106. 1
  • [11] Chan K., Han X.D., Kan Y.W. An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen. Proc Natl Acad Sci U S A. 2001;98:4611-4616. 8
  • [12] Patten C.J., Thomas P.E., Guy R.L. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol. 1993;6:511-518. 4
  • [13] Thummel K.E., Lee C.A., Kunze K.L., Nelson S.D., Slattery J.T. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol. 1993;45:1563-1569. 8
  • [14] Nagai H., Matsumaru K., Feng G., Kaplowitz N. Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes. Hepatol Baltim Md. 2002;36:55-64. 1
  • [15] Zimmerman H.J., Maddrey W.C. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatol Baltim Md. 1995;22:767-773. 3
  • [16] Louvet A., Dharancy S., Mathurin P. Therapeutic misadventure with acetaminophen in alcoholics. Presse Med. 2009;38:172-173. 2
  • [17] Shinzawa H., Togashi H., Sugahara K. Acute cholestatic hepatitis caused by a probable allergic reaction to paracetamol in an adolescent. Tohoku J Exp Med. 2001;193:255-258. 3
  • [18] Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009 ; 43 (4) : 342-9.
  • [19] Ferner RE, Dear JW, Bateman DN. Management of paracetamol poisoning. BMJ 2011 ; 342 : d2218.
  • [20] Schmidt L.E. Age and paracetamol self-poisoning. Gut. 2005;54:686-690. 5
  • [21] Danan G., Teschke R. RUCAM in drug and herb induced liver injury: The update. Int J Mol Sci. 2015;17. 1
  • [22] Rumack BH. Acetaminophen misconceptions. Hepatol Baltim Md 2004 ; 40 (1) : 10-5.
  • [23] Kullak-Ublick G.A., Andrade R.J., Merz M. Drug-induced liver injury: Recent advances in diagnosis and risk assessment. Gut. 2017;66:1154-1164. 6
  • [24] Keays R., Harrison P.M., Wendon J.A. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial. BMJ. 1991;303:1026-1029. 6809
  • [25] Buckley N.A., Whyte I.M., O’Connell D.L., Dawson A.H. Oral or intravenous N-acetylcysteine: Which is the treatment of choice for acetaminophen (paracetamol) poisoning? J Toxicol Clin Toxicol. 1999;37:759-767. 6
  • [26] Smilkstein M.J., Knapp G.L., Kulig K.W., Rumack B.H. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319:1557-1562. 24
  • [27] Chiew AL, Gluud C, Brok J, Buckley NA. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev 2018 ; 2 : CD003328.
  • [28] Sandilands E.A., Bateman D.N. Adverse reactions associated with acetylcysteine. Clin Toxicol Phila Pa. 2009;47:81-88. 2
  • [29] Waring W.S., Stephen A.F., Robinson O.D., Dow M.A., Pettie J.M. Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol Phila Pa. 2008;46:496-500. 6
  • [30] Mant T.G., Tempowski J.H., Volans G.N., Talbot J.C. Adverse reactions to acetylcysteine and effects of overdose. Br Med J Clin Res Ed. 1984;289:217-219. 6439
  • [31] Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet Lond Engl 2010 ; 376 (9736) : 190-201.
  • [32] Bernal W, Wang Y, Maggs J, et al. Development and validation of a dynamic outcome prediction model for paracetamol-induced acute liver failure: A cohort study. Lancet Gastroenterol Hepatol 2016 ; 1 (3) : 217-25.
  • [33] Cholongitas E., Theocharidou E., Vasianopoulou P. Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transplant. 2012;18:405-412. 4
  • [34] Bernal W., Donaldson N., Wyncoll D., Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: A cohort study. Lancet Lond Engl. 2002;359:558-563. 9306
  • [35] Dear JW, Clarke JI, Francis B, et al. Risk stratification after paracetamol overdose using mechanistic biomarkers : results from two prospective cohort studies. Lancet Gastroenterol Hepatol 2018 ; 3 (2) : 104-13.
  • [36] Russo M.W., Galanko J.A., Shrestha R., Fried M.W., Watkins P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transplant. 2004;10:1018-1023. 8
  • [37] Karvellas C.J., Safinia N., Auzinger G. Medical and psychiatric outcomes for patients transplanted for acetaminophen-induced acute liver failure: A case-control study. Liver Int. 2010;30:826-833. 6
  • [38] Hawton K., Bergen H., Simkin S. Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England and Wales: Interrupted time series analyses. BMJ. 2013;346:f403.
  • [39] Mudawi H.M.Y., Yousif B.A. Fulminant hepatic failure in an African setting: Etiology, clinical course, and predictors of mortality. Dig Dis Sci. 2007;52:3266-3269. 11
  • [40] Bernal W., Auzinger G., Wendon J. Prognostic utility of the bilirubin lactate and etiology score. Clin Gastroenterol Hepatol. 2009;7:249. 2author reply 249
  • [41] Larson A.M., Polson J., Fontana R.J. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatol Baltim Md. 2005;42:1364-1372. 6
  • [42] Ostapowicz G., Fontana R.J., Schiødt F.V. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947-954. 12
  • [43] Hadem J., Stiefel P., Bahr M.J. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol. 2008;6:339-345. 3
  • [44] Wei G., Bergquist A., Broomé U. Acute liver failure in Sweden : etiology and outcome. J Intern Med. 2007;262:393-401. 3
  • [45] Escorsell A., Mas A., de la Mata M. Acute liver failure in Spain : analysis of 267 cases. Liver Transplant. 2007;13:1389-1395. Spanish Group for the Study of Acute Liver Failure10
  • [46] Areia M., Romãozinho J.M., Ferreira M., Amaro P., Leitão M.C. Fulminant hepatic failure: A Portuguese experience. Eur J Gastroenterol Hepatol. 2007;19:665-669. 8
  • [47] Miyake Y., Iwasaki Y., Makino Y. Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. J Gastroenterol Hepatol. 2007;22:855-861. 6
  • [48] Brandsaeter B., Höckerstedt K., Friman S. Fulminant hepatic failure: Outcome after listing for highly urgent liver transplantation-12 years experience in the nordic countries. Liver Transplant Soc. 2002;8:1055-1062. 11
  • [49] Gow P.J., Jones R.M., Dobson J.L., Angus P.W. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J Gastroenterol Hepatol. 2004;19:154-159. 2
  • [50] Farmer D.G., Anselmo D.M., Ghobrial R.M. Liver transplantation for fulminant hepatic failure: Experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237:666-675. 5discussion 675-676
  • [51] Shakil A.O., Kramer D., Mazariegos G.V., Fung J.J., Rakela J. Acute liver failure : clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transplant. 2000;6:163-169. 2
  • [52] Williams R., Wendon J. Indications for orthotopic liver transplantation in fulminant liver failure. Hepatol Baltim Md. 1994;20:S5-10S. 1 Pt 2